Clinical Development of Senza5TM CART5: a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+ Nodal T-Cell Lymphomas

Autor: Patel, Ruchi P., Ghilardi, Guido *, Porazzi, Patrizia *, Yang, Steven *, Qian, Dean *, Pajarillo, Raymone *, Wang, Michael *, Zhang, Yunlin *, Schuster, Stephen J., Barta, Stefan K., Nimmagadda, Aditya *, Snook, Adam *, Siciliano, Nicholas A. *, Ruella, Marco
Zdroj: In Blood 15 November 2022 140 Supplement 1:1604-1605
Databáze: ScienceDirect